Problems and countermeasures on the centralized drug procurement in large quantities in public hospitals
10.3760/cma.j.cn111325-20210726-00674
- VernacularTitle:公立医院药品集中带量采购中存在的问题及对策
- Author:
Xuepeng GONG
1
;
Dong LIU
;
Yingying WEI
;
Hongbin YANG
;
Shunda CHEN
;
Guofang HE
Author Information
1. 华中科技大学同济医学院附属同济医院药学部，武汉 430030
- Keywords:
Group purchasing;
Policy making;
Centralized drug procurement in large quantities;
Hospitals, public
- From:
Chinese Journal of Hospital Administration
2021;37(10):827-830
- CountryChina
- Language:Chinese
-
Abstract:
Centralized drug procurement in large quantities is a major step to deepen the medical and healthcare system reform, to improve the mechanism of drug price formation, and to give full play to the role of medical insurance in guiding drug prices in China. Combined with the practice of centralized drug purchasing in public hospitals, the authors sorted out the practical problems and causes from four aspects which affected the implementation of centralized drug purchasing policy in public hospitals: selection on centrally purchased drugs, procurement and supply, clinical use, and hospital financial operation. On this basis, suggestions were put forward to provide reference for the normalization of centralized drug procurement work, such as coordinating national and regional drug collection policies, reasonably setting distribution costs, extending the agreed procurement period, and carrying out special evaluation for drug collection.
